Patents by Inventor Wai Yip Thomas Lee

Wai Yip Thomas Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230132557
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: December 29, 2022
    Publication date: May 4, 2023
    Applicant: Scipio Life Sciences Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Publication number: 20230124467
    Abstract: Compounds and compositions, for example vardenafil, for treating diseases and/or conditions caused by, arising from, and/or associated with coronavirus in a subject, for example a subject infected with SARS-CoV-2 or other coronavirus. Combinations of agents useful for treating diseases and/or conditions caused by, arising from, and/or associated with coronavirus in a subject, for example, vardenafil and Remdesivir, are also provided.
    Type: Application
    Filed: March 3, 2021
    Publication date: April 20, 2023
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON
  • Patent number: 11571422
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Grant
    Filed: October 5, 2021
    Date of Patent: February 7, 2023
    Assignee: SCIPIO LIFE SCIENCES LIMITED
    Inventors: Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai, Junzhe Huang, Ho Yin Li
  • Publication number: 20220023297
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: October 5, 2021
    Publication date: January 27, 2022
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Patent number: 11166952
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: November 9, 2021
    Assignee: APTORUM THERAPEUTICS LIMITED
    Inventors: Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai, Junzhe Huang, Ho Yin Li
  • Publication number: 20210161892
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 3, 2021
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Patent number: 10940459
    Abstract: Molecularly imprinted polymers (MIPs) capable of binding acetate and other target molecules, processes for their production, pharmaceutical compositions comprising the MIPs, and methods of using the MIPs and pharmaceutical compositions for binding target molecules and for treating conditions associated with accumulation of acetate and other target molecules.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 9, 2021
    Assignee: CLAVES LIFE SCIENCES LIMITED
    Inventors: Chi Chiu Ko, Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai
  • Patent number: 10828322
    Abstract: Molecularly imprinted polymers (MIPs) capable of binding acetate and other target molecules, processes for their production, pharmaceutical compositions comprising the MIPs, and methods of using the MIPs and pharmaceutical compositions for binding target molecules and for treating conditions associated with accumulation of acetate and other target molecules.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: November 10, 2020
    Assignee: CLAVES LIFE SCIENCES LIMITED
    Inventors: Chi Chiu Ko, Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai
  • Patent number: 9855248
    Abstract: The present invention provides a new crystalline form of itraconazole as well as the method of making same.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: January 2, 2018
    Assignee: The Chinese University of Hong Kong
    Inventors: Shuai Zhang, Hee Lum Albert Chow, Wai Yip Thomas Lee
  • Publication number: 20170319553
    Abstract: The present invention provides a new crystalline form of itraconazole as well as the method of making same.
    Type: Application
    Filed: April 20, 2017
    Publication date: November 9, 2017
    Inventors: Shuai Zhang, Hee Lum Albert Chow, Wai Yip Thomas Lee